HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Common cold and high-dose ipratropium bromide: use of anticholinergic medication as an indicator of reflex-mediated hypersecretion.

AbstractUNLABELLED:
It was our aim to study the role played by parasympathetic reflexes for the amount and physical characteristics of nasal discharge during a common cold, and to define the maximum anti-rhinorrhoea effect obtainable with anticholinergic medication. Fifty adults with naturally acquired colds were treated with a very high dose of the topically active cholinoceptor-antagonists ipratropium bromide in a randomized, double-blind, placebo-controlled study of parallel groups. A dosage of 400 micrograms was given 4 times daily for 3 days, using a specially manufactured high-dosed pressurized aerosol. This treatment resulted in a 56% reduction in the number of nose blowings (p < 0.01) and a 58% reduction in the weight of blown secretions (p < 0.01). Assessment of the "pourability" of the nasal discharge indicated that ipratropium bromide mainly reduces the watery secretions but not the mucopurulent secretions. The high dose of ipratropium bromide caused nose- and mouth-dryness in a considerable number of the patients.
IN CONCLUSION:
(1) during the first days of a common cold about 60% of the nasal discharge is a reflex-mediated product from nasal glands; (2) this type of secretion is predominantly watery; and (3) ipratropium bromide can reduce watery rhinorrhoea in the common cold, but a lower dose is required in order to avoid side effects.
AuthorsB Ostberg, B Winther, P Borum, N Mygind
JournalRhinology (Rhinology) Vol. 35 Issue 2 Pg. 58-62 (Jun 1997) ISSN: 0300-0729 [Print] Netherlands
PMID9299652 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Aerosols
  • Parasympatholytics
  • Ipratropium
Topics
  • Administration, Inhalation
  • Adult
  • Aerosols
  • Double-Blind Method
  • Female
  • Humans
  • Ipratropium (administration & dosage, therapeutic use)
  • Male
  • Middle Aged
  • Nasal Mucosa (metabolism)
  • Parasympathetic Nervous System (physiopathology)
  • Parasympatholytics (administration & dosage, therapeutic use)
  • Rhinitis, Vasomotor (drug therapy, physiopathology)
  • Statistics, Nonparametric

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: